Treatment of refractory thrombotic thrombocytopenic purpura with
Caplacizumab : A case report
- zakaria maat
, - lana awad,
- Mhd Baraa Habib,
- Abdul Aziz Zafar. ,
- afaf albattah
Abstract
Caplacizumab can be used as a treatment for TTP refractory to
plasmapheresis and steroid03 Sep 2021Submitted to Clinical Case Reports 05 Oct 2021Submission Checks Completed
05 Oct 2021Assigned to Editor
14 Oct 2021Reviewer(s) Assigned
24 Oct 2021Review(s) Completed, Editorial Evaluation Pending
24 Oct 2021Editorial Decision: Revise Minor
23 Dec 20211st Revision Received
